Posts tagged “1degreebio”
It's been a big month in the news department for 1DegreeBio, a portfolio company of ours that aids researchers in sourcing and reviewing antibodies. The Toronto-based start-up announced yesterday that it had closed its Series B round of funding, led by a follow-on investment by Digital Science. Philip Armstrong, CEO of Jovian Capital Corporation and 1DegreeBio senior management also participated in the round.
Our colleagues at 1DegreeBio today released their 2012 Antibody Sourcing and Usage Report, a comprehensive report surveying 400 life scientists on their antibody purchasing habits and practices.
The report showed signs of growth in usage levels,...